Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children

Clinical trial NCT01893554 · COMPLETED

Trial details

NCT number

NCT01893554

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-06-01

Primary completion

2023-04-26

Enrollment

88

View on ClinicalTrials.gov